Skip to main content

Peer Review reports

From: Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trial

Original Submission
27 Apr 2021 Submitted Original manuscript
19 Jul 2021 Reviewed Reviewer Report - Martin Goodier
26 Jul 2021 Reviewed Reviewer Report - Stephen Kennedy
30 Jul 2021 Reviewed Reviewer Report - Sowmyanarayanan Thuppal
6 Aug 2021 Reviewed Reviewer Report - Mohammad Taghi Beigmohammadi
5 Oct 2021 Author responded Author comments - Etienne Karita
Resubmission - Version 2
5 Oct 2021 Submitted Manuscript version 2
28 Oct 2021 Reviewed Reviewer Report - Sowmyanarayanan Thuppal
7 Nov 2021 Reviewed Reviewer Report - Stephen Kennedy
9 Nov 2021 Reviewed Reviewer Report - Mohammad Taghi Beigmohammadi
22 Nov 2021 Reviewed Reviewer Report - Muslim Syed
4 Jan 2022 Author responded Author comments - Etienne Karita
Resubmission - Version 3
4 Jan 2022 Submitted Manuscript version 3
Publishing
26 Apr 2022 Editorially accepted
20 Jun 2022 Article published 10.1186/s13063-022-06360-3

You can find further information about peer review here.

Back to article page